Browsing by Author Pavlidis, N.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 108 to 127 of 317 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: a Hellenic Cooperative Oncology Group studyDimopoulos, M. A.; Papadopoulou, M.; Andreopoulou, E.; Papadimitriou, C.; Pavlidis, N.; Aravantinos, G.; Aspropotamitis, A.; Anagnostopoulos, A.; Fountzilas, G.; Michalas, S.; Pectacides, D.24-Nov-2015-
Feasibility study and pharmacokinetics of low-dose paclitaxel in cancer patients with severe hepatic dysfunctionBriasoulis, E.; Karavasilis, V.; Tzamakou, E.; Piperidou, C.; Soulti, K.; Pavlidis, N.24-Nov-2015-
First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): a phase II study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Dimopoulos, A. M.; Papadimitriou, C.; Kalogera-Fountzila, A.; Aravantinos, G.; Bafaloukos, D.; Athanassiades, A.; Nicolaides, C.; Keramopoulos, A.; Pavlidis, N.; Kosmidis, P.; Skarlos, D.24-Nov-2015-
Five tumor markers in lung cancer: significance of total and "lipid"-bound sialic acidKakari, S.; Stringou, E.; Toumbis, M.; Ferderigos, A. S.; Poulaki, E.; Chondros, K.; Dema, A.; Kotsovoulou, V.; Pavlidis, N.24-Nov-2015-
Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvant treatment, in patients with high-risk colon cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Zisiadis, A.; Dafni, U.; Konstantaras, C.; Hatzitheoharis, G.; Papavramidis, S.; Bousoulegas, A.; Basdanis, G.; Giannoulis, E.; Dokmetzioglou, J.; Katsohis, C.; Nenopoulou, E.; Karvounis, N.; Briassoulis, E.; Aravantinos, G.; Kosmidis, P.; Skarlos, D.; Pavlidis, N.24-Nov-2015-
Fluorouracil and leucovorin with or without interferon alfa-2b in advanced colorectal cancer: analysis of a prospective randomized phase III trial. Hellenic Cooperative Oncology GroupKosmidis, P. A.; Tsavaris, N.; Skarlos, D.; Theocharis, D.; Samantas, E.; Pavlidis, N.; Briassoulis, E.; Fountzilas, G.24-Nov-2015-
Forty years experience of treating cancer of unknown primaryPavlidis, N.24-Nov-2015-
Fourteen years of evolution of ESMO Guidelines: from the minimum recommendations to the Consensus Conference-derived guidelinesPavlidis, N.; Stahel, R.; Hansen, H.; Cervantes, A.24-Nov-2015-
G-CSF induces elevation of circulating CA 15-3 in breast carcinoma patients treated in an adjuvant settingBriasoulis, E.; Andreopoulou, E.; Tolis, C. F.; Bairaktari, E.; Katsaraki, A.; Dimopoulos, M. A.; Fountzilas, G.; Seferiadis, C.; Pavlidis, N.24-Nov-2015-
Gastrointestinal, urologic and lung malignancies during pregnancyPentheroudakis, G.; Pavlidis, N.24-Nov-2015-
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic Cooperative Oncology GroupNicolaides, C.; Dimopoulos, M. A.; Samantas, E.; Bafaloukos, D.; Kalofonos, C.; Fountzilas, G.; Razi, E.; Kosmidis, P.; Pavlidis, N.24-Nov-2015-
Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II studySkarlos, D. V.; Kalofonos, H. P.; Fountzilas, G.; Dimopoulos, M. A.; Pavlidis, N.; Razis, E.; Economopoulos, T.; Pectasides, D.; Gogas, H.; Kosmidis, P.; Bafaloukos, D.; Klouvas, G.; Kyratzis, G.; Aravantinos, G.24-Nov-2015-
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trialPentheroudakis, G.; Kalogeras, K. T.; Wirtz, R. M.; Grimani, I.; Zografos, G.; Gogas, H.; Stropp, U.; Pectasides, D.; Skarlos, D.; Hennig, G.; Samantas, E.; Bafaloukos, D.; Papakostas, P.; Kalofonos, H. P.; Pavlidis, N.; Fountzilas, G.24-Nov-2015-
Global profiling of EGFR gene mutation, amplification, regulation and tissue protein expression in unknown primary carcinomas: to target or not to target?Dova, L.; Pentheroudakis, G.; Georgiou, I.; Malamou-Mitsi, V.; Vartholomatos, G.; Fountzilas, G.; Kolaitis, N.; Kitsiou, E.; Pavlidis, N.24-Nov-2015-
Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development groupBriasoulis, E.; Pavlidis, N.; Terret, C.; Bauer, J.; Fiedler, W.; Schoffski, P.; Raoul, J. L.; Hess, D.; Selvais, R.; Lacombe, D.; Bachmann, P.; Fumoleau, P.24-Nov-2015-
Heterogeneity in cancer guidelines: should we eradicate or tolerate?Pentheroudakis, G.; Stahel, R.; Hansen, H.; Pavlidis, N.24-Nov-2015-
High levels of topoisomerase IIalpha protein expression in diffuse large B-cell lymphoma are associated with high proliferation, germinal center immunophenotype, and response to treatmentPentheroudakis, G.; Goussia, A.; Voulgaris, E.; Nikolaidis, K.; Ioannidou, E.; Papoudou-Bai, A.; Grepi, K.; Kanavaros, P.; Pavlidis, N.; Bai, M.24-Nov-2015-
High-dose epirubicin and r-met-hu G-CSF (filgrastim) in the treatment of patients with advanced breast cancer: A Hellenic Cooperative Oncology Group studyFountzilas, G.; Skarlos, D.; Katsohis, C.; Pavlidis, N.; Giannakakis, T.; Bafaloukos, D.; Fahantidis, E.; Klouvas, G.; Beer, M.; Kosmidis, P.24-Nov-2015-
Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistant paclitaxel-pretreated ovarian cancerAravantinos, G.; Dimopoulos, M. A.; Kosmidis, P.; Bafaloukos, D.; Papadimitriou, C.; Kiamouris, C.; Pavlidis, N.; Sikiotis, K.; Papakostas, P.; Skarlos, D. V.24-Nov-2015-
Immunization of patients with Sjogren's syndrome with pneumococcal polysaccharide vaccine: a randomized trialKarsh, J.; Pavlidis, N.; Schiffman, G.; Moutsopoulos, H. M.24-Nov-2015-